The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kozlovskiĭ V.L.

FGBU "Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva", Sankt-Peterburg

Ronzhina O.S.

Bekhterev Psychoneurological Research Institute, St. Petersburg, Russia

Nosospecific anxiety and a spectrum of anxiolytic activity of psychotropic drugs

Authors:

Kozlovskiĭ V.L., Ronzhina O.S.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(4): 96‑101

DOI: 10.17116/jnevro20171174196-101

Views: 1368

Downloaded: 22

Download PDF (RU)
Contact the author
Table of contents

NOSOSPECIFIC ANXIETY AND A SPECTRUM OF ANXIOLYTIC ACTIVITY OF PSYCHOTROPIC DRUGS
NOSOSPECIFIC ANXIETY AND A SPECTRUM OF ANXIOLYTIC ACTIVITY OF PSYCHOTROPIC DRUGS

To cite this article:

Kozlovskiĭ VL, Ronzhina OS. Nosospecific anxiety and a spectrum of anxiolytic activity of psychotropic drugs. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(4):96‑101. (In Russ.)
https://doi.org/10.17116/jnevro20171174196-101

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Close metadata
Recommended articles:
Therapy of mental diso­rders in patients with hema­tological mali­gnancies. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):127-136
Posttraumatic stress diso­rder clinical guidelines and treatment standards: focus on the symptoms of the psychophysiological arousal. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):58-68
Asthenia in young patients and possibilities for its correction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):133-137
Trait and state anxiety, symptoms of inso­mnia and their influence on daytime functioning in adolescent girls. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5-2):66-71
Reco­gnan (citicoline) in the correction of asthenic and anxiety-depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):43-47
The asso­ciation of single-nucleotide poly­morphism rs6265 of the brain-derived neurotrophic factor gene with clinical features in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):82-88
Effi­cacy and safety of Aviandr in the treatment of anxiety in patients with adju­stment diso­rders after COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):131-138
Dete­rmining the risk of mala­daptation using an electroencephalogram to prevent mental strain. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8):97-102
Oral seda­tion in pediatric outpatient dentistry. Stomatology. 2024;(3):42-49
The syndrome of psycho-sensory-anatomical-functional auto-desadaptation in patients with mali­gnant tumors of the maxi­llofacial region. Stomatology. 2024;(4):20-27

The article discusses the pathogenetic mechanisms of anxiety in different psychiatric disorders. The influence of anxiety on the course, pharmacotherapeutic treatment with respect to the pathogenesis and the possible neurochemical imbalance in the definite type of anxiety are discussed. An anti-anxiety effect in the action of psychotropic drugs is described. It is proposed that neurochemical disturbances are not the same with the various types of anxiety, which requires using drugs from various groups to achieve treatment of the symptom on the pathogenetic level. The various roles of anxiety in the course of different mental disorders is suggested.

Keywords:

anxiety
psychopharmacotherapy
psychotropic drugs
neurochemical aspects of anxiety

Authors:

Kozlovskiĭ V.L.

FGBU "Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva", Sankt-Peterburg

Ronzhina O.S.

Bekhterev Psychoneurological Research Institute, St. Petersburg, Russia

List of references:

  1. Nuller YuL. Trevoga i ee terapiya. Psikhiatriya i psikhofarmakoterapiya im. P.B. Gannushkina. SPb.: Psikhonevrologicheskii institut im. V.M. Bekhtereva. 2002. (In Russ.).
  2. Sel'e G. Na urovne tselogo organizma. M.: Nauka; 1972. (In Russ.).
  3. Tsigos C, Chrousos GP. Hypothalamic — pituitary — adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002;53(4):865-871.
  4. Kutlu MG, Gould TJ. Nicotine modulation of fear memories and anxiety: Implications for learning and anxiety disorders. Biochemical Pharmacology. 2015;97(4):498-511. doi:10.1016/j.bcp.2015.07.029
  5. Tochilov VA. Ob issledovanii struktury i lechenii affektivnykh pristupov. Obozrenie psikhiatrii i meditsinskoi psikhologii. 1992;(2):28-36. (In Russ.).
  6. Tochilov VA, Shirokov VD. Ispol'zovanie seduksenovogo testa pri issledovanii struktury i vybora terapii trevozhno-depressivnykh sostoyanii. Malye trankvilizatory v lechenii i reabilitatsii bol'nykh psikhonevrologicheskimi i psikhosomaticheskimi zabolevaniyami. L. 1979. (In Russ.).
  7. Rapee RM, Barlow DH. (Eds). Chronic anxiety. New York: The Guilford Pres; 1991.
  8. Nuller YuL. Paradigmy v psikhiatrii. Kiiv: Vidannya Asotsiats ii psikhiatriv Ukraini; 1993. (In Russ.).
  9. Psikhiatriya: natsional'noe rukovodstvo. Pod red. Dmitrievoi T.B., Krasnova V.N., Neznanova N.G., Semke V.Ya., Tiganova A.S., Aleksandrovskogo Yu.A. M.: Izdatel'stvo GEOTAR-Media; 2014. (In Russ.).
  10. Lapin IP. Anksiogeny v modelyakh dlya otbora i issledovaniya protivotrevozhnykh preparatov. Nauchno-metodologicheskie aspekty biologicheskikh issledovanii novykh lekarstvennykh preparatov. Riga: Zinatne; 1987. (In Russ.).
  11. File SE, Kenny PJ, Cheeta S. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol Biochem Behav. 2000;66(1):65-72.
  12. Kutlu MG, Gould TJ. Nicotine modulation of fear memories and anxiety: Implications for learning and anxiety disorders. Biochem Pharmacol. 2015;97(4):498-511. doi:10.1016/j.bcp.2015.07.029
  13. Sher L. The role of the endogenous opioid system in the pathogenesis of anxiety disorders. Medical Hypotheses. 1998;50:473-474.
  14. Handley R, Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ‘fear’-motivated behavior. Naunyn-Schmiedebergs Arch Pharmacol. 1984;327(1):105; 23.
  15. Simon P, Panissaud C, Costentin J. Anxiogenic-like effects induced by stimulation of dopamine receptorst. Pharmacol Biochem Behav. 1993;45(3):685-690.
  16. Gafford GM, Ressler KJ. GABA and NMDA receptors in CRF neurons have opposing effects in fear acquisition and anxiety in central amygdala vs. bed nucleus of the stria terminalis. Horm Behav. 2015;76:136-142. doi:10.1016/j.yhbeh.2015.04.001
  17. Stahl SM. Essential Psychopharmacology. Neuroscientific basis and practical application. New York: Cambridge Universisty Press; 2013.
  18. Shin LM, Liberzon I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology. 2010;35(1):169-191. doi:10.1038/npp.2009.83
  19. David DJ, Gardier AM. The pharmacological basis of the serotonin system: Application to antidepressant response. Encephale. 2016;42(3):255-63. doi:10.1016/j.encep.2016.03.012
  20. Sundstrom-Poromaa I, Smith DH, Gong QH, Sabado TN, Li X, Light A, Wiedmann M, Williams K, Smith SS. Hormonally regulated alpha(4)beta(2)delta GABA(A) receptors are a target for alcohol. Nat Neurosci. 2002;5(8):721-722. doi:10.1038/nn888
  21. Ticku MK. Alcohol and GABA-benzodiazepine receptor function. Ann Med. 1990;22(4):241-246.
  22. Ticku MK. Ethanol and the benzodiazepine — GABA receptor — ionophore complex. Experientia. 1989;45(5):413-418.
  23. Gilpin NW, Herman MA, Roberto M. The Central Amygdala as an Integrative Hub for Anxiety and Alcohol Use Disorders. Biol Psychiatry. 2015;77(10):859-869. doi:10.1016/j.biopsych.2014.09.008
  24. Orlikov A.B. O klinicheskoi tipologii trevozhnykh sostoyanii. Obozrenie psikhiatrii i meditsinskoi psikhologii im. V.M. Bekhtereva. 1992;1:57-64.
  25. Klinicheskie razbory v psikhiatricheskoi praktike. Pod red. Gofmana A.G. M.: Izdatel'stvo MEDpress-inform; 2006.
  26. Simon P, Panissaud C, Costentin J. Sulpiride anxiogenic-like effect inhibition by a D1 dopamine receptor antagonist. Neuroreport. 1992;3(10):941-942.
  27. Popov MYu. Trevoga v strukture ostrykh psikhoticheskikh sostoyanii kak obosnovanie podkhodov k terapii. Psikhiatriya i psikhofarmakoterapiya. 2002;4(2): 54. (In Russ.).
  28. Nuller YuL, Mikhalenko IN. Affektivnye psikhozy. L.: Meditsina; 1988. (In Russ.).
  29. Limanskii YuP. Morfofunktsional'naya organizatsiya aminergicheskikh sistem i ikh rol' v motornoi deyatel'nosti mozga. Uspekhi fiziologicheskikh nauk. 1990;21(2):3-17. (In Russ.).
  30. Shatsberg AF, Cole DO, DeBattista Ch. The Manual of clinical psychopharmacology. M.: Medpress-inform; 2014. (In Russ.).
  31. Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C, Alsobrook J, Peterson BS, Cohen DJ, Rasmussen SA, Goodman WK, McDougle CJ, Pauls DL. Symptoms of obsessive-compulsive disorder. Am J Psychiatry. 1997;154(7):911-917. doi:10.1176/ajp.154.7.911
  32. Psikhiatriya: natsional'noe rukovodstvo. Pod red. Dmitrievoi T.B., Krasnova V.N., Neznanova N.G., Semke V.Ya., Tiganova A.S., Aleksandrovskogo Yu.A. M.: Izdatel'stvo GEOTAR-Media; 2014. (In Russ.).
  33. Zwanzger P. Pharmacotherapy of Anxiety Disorders. Fortschr Neurol Psychiatr. 2016;84(5):306-314. doi:10.1055/s-0042-106764
  34. Kozlovskii VL. Pochemu protivoepilepticheskie preparaty yavlyayutsya timostabilizatorami (psikhofarmakologiya protivoepilepticheskikh sredstv). Sotsial'naya i klinicheskaya psikhiatriya. 2015;25(4):72-78. (In Russ.).
  35. Curran C, Byrappa N, McBride A. Stimulant psychosis: systematic review. The British Journal of Psychiatry. 2004;185:196-204. doi:10.1192/bjp.185.3.196
  36. Enna SJ. Role of gamma-aminobutyric acid in anxiety. Psychopharmacology. 1984;17(suppl 1):15-24.
  37. Celentano JJ, Gibbs TT, Farb DH. Ethanol potentiates GABA- and glycine-induced chloride currents in chick spinal cord neurons. Brain Res. 1988;455:377-380.
  38. Michaelis E, Roy S, Galton N, Cunningham M, Lecluyse E, Michaelis M. Correlation of glutamate binding activity with glutamate-binding protein immunoreactivity in the brain of control and alcohol-treated rats. Neurochem Int. 1987;11(2):209-218.
  39. Kushner MG, Abrams K, Borchardt C. The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clin Psychol Rev. 2000;20(2):149-171.
  40. Pedrelli P, Shapero B, Archibald A, Dale C. Alcohol use and depression during adolescence and young adulthood: a summary and interpretation of mixed findings. Curr Addict Rep. 2016;3(1):91-97. doi:10.1007/s40429-016-0084-0

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.